Anson Funds Management LP 13D and 13G filings for TransCode Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-02-14 5:16 pm Purchase | 2024-12-31 | 13G | TransCode Therapeutics, Inc. RNAZ | Anson Funds Management LP | 113,479 9.900% | 113,479![]() (New Position) | Filing |